In a diabetic patient with positive urine ketones, what is the appropriate management?

Management of Diabetic Patient with Positive Urine Ketones

In a diabetic patient with positive urine ketones, you must immediately assess for diabetic ketoacidosis (DKA) by checking blood glucose, arterial or venous blood gas for pH and bicarbonate, and serum ketones, then initiate treatment based on DKA severity with intravenous fluids, continuous insulin infusion for moderate-to-severe cases, and careful potassium monitoring. 1

Initial Assessment Algorithm

When you encounter positive urine ketones in a diabetic patient, follow this structured approach:

1. Immediate Laboratory Evaluation

• Blood glucose level (DKA typically >250 mg/dL, but euglycemic DKA can occur)
• Arterial or venous blood gas for pH and bicarbonate
  • pH <7.3 indicates DKA 1
  • Bicarbonate <18 mEq/L supports diagnosis 2
• Serum ketones (more accurate than urine ketones)
• Electrolytes including potassium
• Anion gap calculation
• Complete blood count, BUN, creatinine 2

2. Severity Classification

The severity determines your treatment pathway:

• Mild-to-moderate DKA: May be treated with frequent subcutaneous insulin injections 1
• Moderate-to-severe DKA: Requires continuous intravenous insulin infusion 3, 1
• Critical illness or mental obtundation: Continuous IV insulin is the standard of care 1

Treatment Protocol

Fluid Resuscitation

Start immediately with intravenous fluids to restore circulatory volume and tissue perfusion 1. While practice varies globally (with 29% using isotonic saline only, 38% using balanced solutions only, and 33% using both 4), the key is rapid volume replacement to correct the hyperosmolar state and hypovolemia.

Insulin Therapy

For moderate-to-severe DKA:

• Continuous IV insulin infusion is the standard 3, 1
• Initial bolus practices vary (49% of clinicians use it 4)
• Common starting dose: 0.1 U/kg/h 4
• Some protocols base initial dose on blood glucose levels (35% of clinicians) or ketones (8%) 4

Critical pitfall: Do not stop IV insulin until ketoacidosis resolves, even if glucose normalizes. Insufficient glucose supplementation with inadequate insulin can cause persistent ketoacidosis despite euglycemia 5. When glucose drops to approximately 200 mg/dL, add dextrose-containing fluids while continuing insulin to clear ketones.

Potassium Management

This is essential and commonly overlooked: Hypokalaemia occurs in approximately 50% of DKA cases during treatment, and severe hypokalaemia (<2.5 mEq/L) is associated with increased mortality 3. Monitor potassium levels frequently with both laboratory tests and ECG monitoring 3.

Monitoring Parameters

Track these continuously on a flow sheet:

• Blood glucose (hourly initially)
• pH and bicarbonate (arterial or venous blood gases - venous is acceptable and more commonly used in experienced ICUs 4)
• Electrolytes, especially potassium
• Anion gap
• Vital signs
• Mental status

Transition to Subcutaneous Insulin

Do not transition until ALL of the following are met 3:

• Stable glucose for 4-6 hours consecutively
• Normal anion gap
• Resolution of acidosis
• Hemodynamic stability (not requiring vasopressors)
• Stable nutrition plan
• Stable IV insulin infusion rates

Critical timing: Administer basal subcutaneous insulin 2-4 hours before stopping IV insulin to prevent rebound hyperglycemia and recurrent ketoacidosis 1. Calculate the subcutaneous dose from the average insulin infused during the preceding 12 hours (e.g., 1.5 U/h average = 36 U/24h total daily dose) 3.

Special Considerations

Euglycemic DKA

Be alert for DKA with glucose <250 mg/dL, which can occur with SGLT2 inhibitors, pregnancy, or reduced carbohydrate intake. The presence of ketones with acidosis defines DKA regardless of glucose level 6.

Underlying Precipitants

Always identify and treat the trigger:

• Infection/sepsis (most common)
• Myocardial infarction
• Stroke
• Medication non-compliance
• New-onset diabetes (occurs in one-third of DKA cases 2)

Bicarbonate Use

Generally not recommended - studies show no difference in acidosis resolution or time to discharge, and it may cause harm 1.

ICU Admission Criteria

Consider ICU admission for 4:

• pH <7.20
• Bicarbonate <15 mmol/L
• Need for continuous IV insulin
• Mental status changes
• Hemodynamic instability

Common Pitfalls to Avoid

1. Stopping IV insulin too early when glucose normalizes but ketoacidosis persists
2. Inadequate potassium monitoring and replacement leading to life-threatening arrhythmias
3. Failing to overlap subcutaneous and IV insulin during transition, causing rebound DKA
4. Missing euglycemic DKA by focusing only on glucose levels
5. Not identifying the precipitating cause, leading to recurrent episodes

1